Compare VYNE & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VYNE | SPPL |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0M | 17.4M |
| IPO Year | 2018 | 2023 |
| Metric | VYNE | SPPL |
|---|---|---|
| Price | $0.59 | $2.89 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 418.2K | 4.0K |
| Earning Date | 03-05-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $524,000.00 | ★ $4,591,508.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.67 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 6.29 | ★ 24.27 |
| 52 Week Low | $0.28 | $2.18 |
| 52 Week High | $2.94 | $7.00 |
| Indicator | VYNE | SPPL |
|---|---|---|
| Relative Strength Index (RSI) | 68.94 | 34.59 |
| Support Level | $0.55 | $2.97 |
| Resistance Level | $0.57 | $3.25 |
| Average True Range (ATR) | 0.02 | 0.27 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 91.01 | 34.95 |
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.